Inotek Raises Series C

Inotek Pharmaceuticals Corp., a Beverly, Mass.-based drug development company, has raised $19.3 million in Series C funding. Return backers included Care Capital, La Caisse de depot et placement du Quebec, MedImmune Ventures, Pitango Venture Capital and Rho Ventures. New investors were Hercules Technology Growth Capital, Meditor Capital Management and Mitsubishi UFJ Capital. Inotek has now raised nearly $75 million in total VC funding since 2004. www.inotekcorp.com